Invivyd Inc. (IVVD NASDAQ) stock market data APIs
$1.5897
0.17(10.7%)
as of February 6, 2026
Try our APIs with
free plan!
Invivyd Inc. Financial Data Overview
Price chart is built with
Anychart
Invivyd, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's pipeline includes PEMGARDA (pemivibart) injection, a half-life extended investigational monoclonal antibody (mAb) for the prevention of COVID-19 in adults and adolescents; VYD2311, an mAb candidate, which is in preclinical studies for the prevention or treatment of COVID-19; and Adintrevimab that is in phase 2/3 clinical trials for the prevention and treatment of COVID-19. It also has discovery stage candidates for the prevention of seasonal influenza and COVID-19. The company has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies. The company was formerly known as Adagio Therapeutics, Inc. and changed its name to Invivyd, Inc. in September 2022. Invivyd, Inc. was incorporated in 2020 and is headquartered in Waltham, Massachusetts.
Prev. Close
1.5897
Open
1.7625
High
1.8083
Low
1.5884
52 wk Range
0.46-3.0699
Market Cap
482 M
Shares Outstanding
282 M
Revenue
50 039 K
EPS
-0.06
Beta
0.604
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Invivyd Inc. (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Invivyd Inc. data using free add-ons & libraries
Get Invivyd Inc. Fundamental Data
Invivyd Inc. Fundamental data includes:
- Net Revenue: 50 039 K
- EBITDA: -60 544 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-06
- EPS/Forecast: -0.07
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Invivyd Inc. News
New
Invivyd (IVVD) Reports Strong Q4 Growth, Advances COVID Antibody to Phase 3
Invivyd, Inc. (NASDAQ:IVVD) is one of the best penny stocks to buy in 2026. On January 8, Invivyd, Inc. (NASDAQ:IVVD) reported preliminary fourth-quarter 2025 net product revenue of $17.2 million from...
Invivyd Reports Preliminary Fourth Quarter 2025 Revenue and Recent Business Highlights
Preliminary Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth quarter-over-quarterPreliminary ending 2025 cash and cash equiva...
BTIG Initiates Invivyd (IVVD) Coverage, Cites VYD2311’s Superior Market Potential Over Pemgarda
Invivyd Inc. (NASDAQ:IVVD) is one of the best biotech penny stocks to buy according to analysts. On December 22, BTIG analyst Thomas Shrader initiated coverage of Invivyd with a Buy rating and $10 pri...
Does Invivyd’s (IVVD) Index Debut Reveal a Turning Point in Its Biotech Credibility?
Invivyd, Inc. was recently added to both the NASDAQ Biotechnology Index and the S&P Biotechnology Select Industry Index, increasing its presence among publicly traded biotech peers. This twin index in...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
